# FDA Inspection 1260044 - Prinston Pharmaceutical Inc - August 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/aa126585-d984-4276-a092-4a42ecfefeb1
Source feed: FDA_Inspections

> FDA Inspection 1260044 for Prinston Pharmaceutical Inc on August 26, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260044
- Company Name: Prinston Pharmaceutical Inc
- Inspection Date: 2025-08-26
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1260044 - 2025-08-26](https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/5325905e-342f-4328-8f50-e286c07aa6a8)
- [FDA Inspection 967278 - 2016-04-05](https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/5fe1627e-8b92-47cd-9437-310a0a8a70e6)
- [FDA Inspection 808907 - 2012-11-30](https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/ae4fc011-4244-4744-a9ab-8bea1d2eb319)

Company: https://www.keypedia.com/companies/prinston-pharmaceutical-inc/72ffd69b-9c04-4962-af92-315100419ae8

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248